Literature DB >> 24511008

Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-α in morphological changes of ovarian cancerous cells.

Benjamin Piura1, Liat Medina, Alex Rabinovich, Victor Dyomin, Ruthy Shaco Levy, Mahmoud Huleihel.   

Abstract

BACKGROUND/AIM: It has been previously shown that epithelial ovarian carcinoma tissues express high levels of tumor necrosis alpha (TNF-α), interleukin (IL)-6, IL-1α and IL-1β. The aim of the present study was to evaluate the localization of TNF-α and its receptors (TNFR1 and TNFR2) in different types of ovarian carcinoma tissues and the possible role of TNF in the pathogenesis of epithelial ovarian carcinoma.
MATERIALS AND METHODS: Total RNA was extracted from normal and cancerous ovarian tissues and mRNA was analyzed with semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Immunohistochemical staining was performed with use of antibodies against human (ah)TNFR1 and TNF2.
RESULTS: TNF-α mRNA and TNFR2 mRNA levels were significantly higher in ovarian carcinoma tissues than in normal ovarian tissues, whereas TNFR1 mRNA levels were similar. TNFR1 and TNFR2 were mainly localized in the epithelial neoplastic cells of the tumor. Knocking-down TNF-α activity with αhTNF-a altered ovarian carcinoma cell morphology (with more branches) in vitro.
CONCLUSION: Our study indicates a possible role of TNF-α in epithelial ovarian carcinoma pathogenesis through TNFR2, which affects morphological changes, which may be involved ovarian cancer pathogenesis.

Entities:  

Keywords:  Ovarian carcinoma; TNF-α; TNFR; cell morphology

Mesh:

Substances:

Year:  2014        PMID: 24511008

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer.

Authors:  Rosekeila Simões Nomelini; Luciano Eliziário Borges Júnior; Cid Almeida de Lima; Ana Flávia Carrijo Chiovato; Douglas Côbo Micheli; Beatriz Martins Tavares-Murta; Eddie Fernando Candido Murta
Journal:  Clin Exp Med       Date:  2018-05-25       Impact factor: 3.984

2.  TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?

Authors:  Mamta Gupta; Ana Babic; Andrew H Beck; Kathryn Terry
Journal:  Hum Pathol       Date:  2016-04-08       Impact factor: 3.466

3.  Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.

Authors:  Wei Wang; Jinhua Wu; Abir Mukherjee; Tianhai He; Xiang-Yang Wang; Yibao Ma; Xianjun Fang
Journal:  FASEB J       Date:  2020-08-26       Impact factor: 5.191

4.  Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.

Authors:  Anne M Noonan; Kristen P Bunch; Jin-Qiu Chen; Michelle A Herrmann; Jung-Min Lee; Elise C Kohn; Ciara C O'Sullivan; Elizabeth Jordan; Nicole Houston; Naoko Takebe; Robert J Kinders; Liang Cao; Cody J Peer; W Douglas Figg; Christina M Annunziata
Journal:  Cancer       Date:  2015-11-13       Impact factor: 6.860

5.  Aquaporin 5 expression is altered in ovarian tumors and ascites-derived ovarian tumor cells in the chicken model of ovarian tumor.

Authors:  Anupama Tiwari; Jill A Hadley; Ramesh Ramachandran
Journal:  J Ovarian Res       Date:  2014-10-25       Impact factor: 4.234

Review 6.  Immune Cell Population in Ovarian Tumor Microenvironment.

Authors:  Dong Li Cai; Li-Ping Jin
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

7.  1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer.

Authors:  Marisa K Kilgour; Sarah MacPherson; Lauren G Zacharias; Abigail E Ellis; Ryan D Sheldon; Elaine Y Liu; Sarah Keyes; Brenna Pauly; Gillian Carleton; Bertrand Allard; Julian Smazynski; Kelsey S Williams; Peter H Watson; John Stagg; Brad H Nelson; Ralph J DeBerardinis; Russell G Jones; Phineas T Hamilton; Julian J Lum
Journal:  Sci Adv       Date:  2021-01-20       Impact factor: 14.136

8.  Expression of IL-18, IL-18 binding protein, and IL-18 receptor by normal and cancerous human ovarian tissues: possible implication of IL-18 in the pathogenesis of ovarian carcinoma.

Authors:  Liat Medina; Alex Rabinovich; Benjamin Piura; Victor Dyomin; Ruthy Shaco Levy; Mahmoud Huleihel
Journal:  Mediators Inflamm       Date:  2014-05-15       Impact factor: 4.711

9.  Oxyresveratrol Inhibits TNF-α-Stimulated Cell Proliferation in Human Immortalized Keratinocytes (HaCaT) by Suppressing AKT Activation.

Authors:  Nitwara Wikan; Phateep Hankittichai; Phatarawat Thaklaewphan; Saranyapin Potikanond; Wutigri Nimlamool
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.